By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



5300 Westview Drive
Suite 406
Frederick  Maryland  21703  U.S.A.
Phone: 301-668-8400 Fax: n/a



Company News
Vaccinogen Names Dr. Peter Morsing As Head Of Business Development 1/12/2015 9:38:51 AM
Vaccinogen Plans Move To Baltimore After $80 Million In New Funding; Will Increase Headcount By 300 Percent 8/27/2014 6:38:53 AM
Vaccinogen Completes Initial Closing Of An $80 Million Financing 8/25/2014 8:11:50 AM
Vaccinogen Names Dr. Benjamin Carson and Dr. Jan B. Vermorken to Medical Advisory Board 10/24/2013 6:36:03 AM
Vaccinogen Announces SEC Clearance of Form 10 Registration Statement and Upgrade to OTC.QB Market 10/18/2013 9:31:41 AM
Vaccinogen to Present at 11th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/26/2012 9:50:52 AM
Vaccinogen Release: Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development 8/28/2012 10:03:10 AM
Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO 10/1/2010 7:57:14 AM
Vaccinogen Selects Clinipace Inc. Worldwide to Manage Global Phase 3b Clinical Trial 5/5/2010 10:26:06 AM
Dutch Authorize Manufacture of Vaccinogen's New Cancer Vaccine; License Clears Path to European Production, Final FDA Trial 5/8/2008 7:16:59 AM